This study aimed to investigate the occurrence of febrile neutropenia in breast cancer patients who received adjuvant combination therapy (CT) without G-CSF prophylaxis at a Brazilian oncology center serving patients with both public and private health insurance. Here, CSF3 is linked to breast cancer.